Real-time enrollment status for this myasthenia gravis clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 12:01 PM UTC
| NCT Number | NCT07039916 |
| Recruiting Status | Recruiting |
| Condition | Myasthenia Gravis |
| Phase | PHASE3 |
| Target Enrollment | 231 participants |
| Active Locations | 48 sites in the US |
| Sponsor | Immunovant Sciences GmbH |
| Last Updated on CT.gov | July 30, 2026 (Jul 30, 2026) |
As of October 15, 2026: Clinical trial NCT07039916 is currently recruiting participants. This phase3 study for myasthenia gravis is actively seeking new participants at 48 locations across the United States. The study is sponsored by Immunovant Sciences GmbH. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07039916 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 48 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07039916 was last updated Jul 30, 2026 (July 30, 2026). HelloStudys verifies this status automatically.